Skip to content
DataLookout
Menu

NCT07895992

SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer : a Randomized Controlled, Open, Multicenter Phase III Study

StatusNot Yet Recruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 1 with changes below, 1 re-verified with no change.

  1. Study First Submitted

Endpoints

Primary

PFS
Timeframe: about 24 months

Secondary (5)

The incidence and grade of adverse events;
OS
ORR
DoR
DCR

Arms and interventions

SHR-A2009 + bevacizumabExperimental
Sacituzumab TirumotecanActive comparator

Drugs: SHR-A2009 + bevacizumab, Sacituzumab Tirumotecan

Sites

1 site in 1 country

  • Guangdong Provincial People's HospitalGuangzhou, Guangdong, China